JHancock3 Growth Opportunities A
601 Congress Street Boston MA 02210
Map
Phone: 800-225-5291
| Category: | Mid-Cap Growth | | Fund Family: | John Hancock | | Net Assets: | 45.78M | | Year-to-Date Return: | 16.45% | | Yield: | 0.00% | | Morningstar Rating: |  | | Fund Inception Date: | 16-Sep-05 |
|
Sam Wilderman
Lead Manager since
12-Jun-06 | | | Wilderman is co-head of the GMO quantitative equity team and lead manager for U.S. quantitative portfolios. Previously at GMO, he was responsible for research and portfolio management for the GMO Emerging Markets Strategies. |
| Min Initial Investment: | $2,500 | | Min Initial Investment, IRA: | $2,500 | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | NaN | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in investments in small- and mid-cap companies. It typically invests in U.S. companies that issue stocks included in the Russell 2500 index and companies with similar market capitalizations. The fund is nondiversified. |
| Last Dividend
| YFT_NOT_APPLICABLE_ABBREVIATION | | Last Cap Gain
(14-Dec-07):
| 0.00 | | Annual Holdings Turnover
| 140.00% | | Average for Category:
| 125.67% |
|
| Expense | GMSGX | Category
Avg | | Total Expense Ratio: | 1.50%
| 1.45% | | Max 12b1 Fee: | 0.30%
| N/A | | Max Front End Sales Load: | 5.00%
| 5.39% | | Max Deferred Sales Load: | %
| 2.68% | | 3 Yr Expense Projection*: |
$ 1,020 | $714 | | 5 Yr Expense Projection*: |
$ 1,420 | $1,046 | | 10 Yr Expense Projection*: |
$ 2,534 | $2,067 |
|
|
1.92% Nasdaq 
Profile
